The relative attributes of these C. albicans forms during the colonization of skin and mucosae, and later in the invasion of the bloodstream and deep tissues, have long been debated [3] [4] [5] [6] . One intriguing aspect of the interaction between the human host and the microbial flora that colonizes the skin and mucosal surfaces is the immunological tolerance of the mucosae to colonizing microorganisms. This contrasts with the induction of potent defence mechanisms following tissue invasion. C. albicans colonizes the skin, genital mucosa and/or intestinal mucosa of 30-70% of healthy individuals at any given moment, and it is therefore noteworthy that under normal circumstances the fungus does not cause significant disease 7 . However, in the absence of proper immune recognition, the inability to control colonizing C. albicans on mucosal surfaces can lead to severe infection (for example, in patients with chronic mucocutaneous candidiasis (CMC)) 8 . Perturbations in the composition of the competitive commensal bacteria can also predispose individuals to C. albicans infections, and distorted immuno logical responses to C. albicans have been proposed to contribute to the pathological autoinflammation that occurs in patients with Crohn's disease 9 .
In this Review, we describe the properties of C. albicans yeast cells and hyphae that are relevant to the interaction with the host, and discuss the immunological consequences of the shifting nature of the fungal cell surface. We discuss the molecular mechanisms that drive the morphogenetic changes of C. albicans from yeast cells to hyphae (a crucial step for invasion), the changes that lead to differential interaction with the host, and the immunological mechanisms that discriminate between tissue colonization and invasion. Although many aspects discussed in this Review could be extrapolated to other microorganisms, we focus on C. albicans as a prototypical fungal pathogen, primarily in relation to the immunological balance between tolerance of colonization and host immunity to invasion.
Morphogenetic changes in the cell wall
The cell wall of C. albicans contains carbohydrates and cell wall proteins (CWPs) that are not present in the human body. The cell wall therefore represents an ideal immunological target to discriminate self from non-self, and consequently the majority of fungal PAMPs (pathogen-associated molecular patterns) that activate and modulate immune responses are cell wall components 10, 11 .
Bud scars
Scars located on the surface of the mother cell, representing the remnants of the septum formed between mother and daughter cells during cell division.
In well-preserved images of the C. albicans cell wall, two main layers can be distinguished: an outer layer that is composed of glycoproteins and an inner layer that contains skeletal polysaccharides (FIG. 2) . The C. albicans cell wall is 80-90% carbohydrate, with the outer layer predominantly consisting of O-and N-linked mannose polymers (mannans) that are covalently associated with proteins to form glycoproteins. The expression of CWPs is highly regulated during the yeast-to-hypha transition, and genes encoding hypha-specific proteins such as hyphal wall protein 1 (Hwp1), hyphally regulated protein 1 (Hyr1) and agglutinin-like sequence 3 (Als3) are among the most highly upregulated genes during this switch [12] [13] [14] [15] [16] . Cytoplasmic immunodominant antigens that are not normally associated with the cell wall have also been recognized 16, 17 . Nevertheless, the hyphaspecific CWPs are major antigens, and they also function as adhesins and invasins that can modulate immune responses 18, 19 . The extent to which the structure of the mannans decorating these CWPs differs in yeast cells and in hyphae is not certain, although it is known that CWPs in hyphae contain fewer phosphodiester-linked β-1,2-manno-oligosaccharides than do CWPs in yeast cells 20 . Other properties of the mannan might also differ between the yeast and hyphal forms.
The inner layer of the cell wall contains the skeletal polysaccharides chitin and β-1,3-glucan, which confer strength and cell shape (FIG. 2) . The CWPs from the outer layer are attached to this framework predominantly by glycosylphosphatidylinositol (GPI) remnants that are linked to the skeletal polysaccharides through a more flexible β-1,6-glucan. In C. albicans yeast cells, chitin normally constitutes ~2% of the cell wall dry weight, whereas β-1,3-glucan and β-1,6-glucan account for 40% and 20%, respectively. However, the chitin content of yeast cells can be increased threefold to fourfold by conditions that affect the cell wall, such as caspofunginmediated inhibition of β-1,3-glucan synthesis 21 . Hyphal cells contain approximately 3-5 times as much chitin as yeast cells 22 . In addition, most chitin in yeast cells resides in the bud scars 23 . Because hyphae have no bud scars, it is likely that the actual chitin content of the lateral cell walls in yeast and hyphae could differ by as much as an order of magnitude. This could be relevant for the interaction with the immune system, as chitin purified from C. albicans blocks recognition of C. albicans yeast cells by monocytes 24 . By contrast, the β-1,3-glucan content of yeast and hyphal cells is similar. However, β-1,3-glucan might be less exposed at the hyphal cell surface than on yeast cells, as it also normally occurs in a considerable amount only at the sites of bud scars 25 . How the structural and chemical properties of the pseudohyphal cell wall differ from those of yeast and hyphal cell walls, and how pseudohyphae differ from yeast cells and hyphae in terms of immune recognition, is presently unknown.
Therefore, although the basic components of the C. albicans cell wall are similar in the yeast and filamentous forms, the surface proteome and the amounts of individual PAMPs presented to immune cells differ substantially. In addition, the conditions under which cells are grown can cause substantial changes in the cell wall, even if the morphology of the cell is unaltered 3 . Owing to its highly regulated and responsive nature, the cell wall represents a moving target that presents a significant challenge for the host immune system.
Regulation of morphogenesis
As described above, cellular morphogenesis in C. albicans is associated with changes in cell wall composition and architecture, and this influences detection by the host immune system and the subsequent immune response. In general, these observations have been made using standard experimental conditions for inducing hypha formation in vitro, including the addition of serum or the use of mutants that are defective in genes encoding regulators of hypha formation, such as the double mutant for Candida pseudohyphal regulator 1 and enhanced filamentous growth 1 (cph1/cph1 efg1/efg1) 26 or the hgc1/hgc1 mutant 27 . However, morphogenesis in C. albicans can be 
Muramyl dipeptide
The minimal structural unit of peptidoglycan in Gram-positive bacteria that is recognized by the intracellular receptor NOD2 (nucleotide-binding oligomerization domaincontaining 2).
Cyclin
A family of proteins for which expression is normally periodic within the cell cycle and which control the progression of cells through the cell cycle by activating cyclin-dependent kinases.
Septins
Evolutionarily conserved proteins that have essential functions in bud evagination and cytokinesis, and more subtle roles throughout the cell cycle.
Chlamydospores
Thick-walled spores that are produced by Candida albicans on carbohydrate-rich media in vivo. The presence of chlamydospores in human tissues has yet to be firmly established.
Genotoxic
Pertaining to a substance: able to cause mutations by damaging DNA.
induced by several mechanisms (FIG. 3) that are activated by various environmental triggers which might have different effects on the fungal cell surface. Therefore, C. albicans probably generates subtly different forms of hyphae in different host niches, thereby affecting the host immune response in a niche-specific manner.
Protein kinase A signalling. Signalling through cyclic AMP-protein kinase A complex (PKA) is the major pathway by which hyphal growth is induced in C. albicans (FIG. 3a) . A range of environmental signals regulate cAMP-PKA signalling, with most inputs being co ordinated through the adenylyl cyclase Cyr1 (also called Cdc35). Some signals appear to act directly on the adenylyl cyclase itself, such as serum muramyl dipeptide (MDP) and CO 2 (REFS 28, 29) . Other signals, such as glucose and amino acids [30] [31] [32] , act indirectly on the adenylyl cyclase by upstream signalling through the small GTPase Ras1 or through guanine-nucleotide-binding (G) protein-coupled receptor 1 (Gpr1) and the associated G protein α2 subunit (Gpa2), respectively. Additional environmental signals influence cAMP-PKA signalling, although their exact mode of action has not yet been clarified. For example, hyphal development is inhibited at temperatures below 35 °C through the action of the molecular chaperone heat shock protein 90 (Hsp90) 33 . Also, the quorum sensing molecule farnesol, which accumulates at high C. albicans cell densities, inhibits hyphal formation by downregulating cAMP-PKA signalling 34 , indicating that cell density probably affects morphogenesis at the site of infection.
Adenylyl cyclase activation leads to an elevated level of cAMP, which causes dissociation of the PKA regulatory subunit (Bcy1) from the catalytic subunits (Tpk1 and Tpk2), thereby activating the kinase. PKA is thereafter thought to phosphorylate and activate the transcription factor Efg1 (REF. 35 ), which is essential for the activation of hypha-specific genes in C. albicans 36 . These genes include those encoding the cell surface adhesins, invasins and immune modulators Als3, Hwp1 and Hyr1, as well as the hypha-specific cyclin Hgc1. Hgc1 interacts with the cyclin-dependent kinase (Cdk) cell division cycle 28 (Cdc28) to mediate phosphorylation of the septins Cdc11 and Sep7, thereby promoting polarized growth and cell separation 37 (FIG. 3a) . These inputs promote the maintenance of hyphal development after polarized growth has been triggered by the Cdc28-Ccn1 (G1-S-specific cyclin) complex, which binds to septin complexes and phosphorylates Cdc11 (REF. 38 ).
Alternative signalling mechanisms. Additional environmental signals stimulate hyphal development through alternative signalling mechanisms (FIG. 3b) . Low levels of nitrogen as a result of starvation activate hyphal development through a mitogen-activated protein kinase (MAPK) cascade as well as the cAMP-PKA pathway. This MAPK cascade, which includes proteins with structural similarity to MAPK components in other organisms (namely, Hst7 and Cek1 (also known as Erk1), subsequently activates the transcription factor Cph1 (REF. 32) (FIG. 3b) . Cph1 also plays a part in pheromone signalling during mating in C. albicans 39 . Whether in response to starvation or mating pheromone, the activation of this MAPK pathway has an important role in the formation of chlamydospores, which are thought to promote C. albicans survival in unfavourable conditions 40 . Ambient pH also influences morphogenesis and CWP synthesis through the Rim101 pathway. Rim101 is a zinc-finger-containing transcription factor that is inactive under acidic conditions but activated at neutral to alkaline conditions and alters gene expression 41, 42 . Hyphal development can also be stimulated by hypoxia and by embedding C. albicans cells in a matrix. These inputs activate morphogenesis through additional alternative pathways that involve the transcription factors Efg1 and Efh1 during hypoxia-induced hypha formation and the morphogenetic regulator Czf1 during matrix-induced hypha formation 43, 44 (FIG. 3b) .
Genotoxic stress. C. albicans morphogenesis can also be driven by other mechanisms. Genotoxic stresses that disturb cell cycle progression can stimulate filamentous growth in C. albicans 45 (FIG. 3c) . For example, mutations that interfere with DNA damage repair, or the pharmacological inhibition of DNA replication (for example with hydroxyurea), can trigger hyphal growth 46, 47 . These genotoxic insults can act through the DNA damage or DNA replication checkpoints to promote hyphal development through Rad53, a checkpoint kinase 45 . Reactive oxygen species generated by phagocytic cells also induce genotoxic stress. For example, hydrogen peroxide activates hyphal development through Rad53 signalling 48 . Therefore, the C. albicans hyphae that escape from macrophages might not be equivalent to the hyphae that invade mucosal surfaces, further complicating the host-pathogen interaction.
Clearly, C. albicans morphogenesis is controlled by a complex regulatory network that coordinates an array 
Zymosan
A cell wall preparation that is obtained from the yeast Saccharomyces cerevisiae and comprises a proteincarbohydrate complex rich in β-1,3-glucan.
of environmental inputs. As a result, not all C. albicans hyphae are identical, and the fungal cell surface will differ depending on the nature of the microenvironment that the cell occupies. This will influence the correspondingly complex network of host immune detection mechanisms and responses. It is interesting to note that the presence of pseudohyphae has yet to be considered in terms of their relevance to pathogenesis and the host immune response.
Morphogenesis and pathogen recognition
How the immune system interacts with the various morpho genetic forms of fungi is poorly understood. In the case of C. albicans, one intriguing possibility is that the differential recognition of yeast cells and hyphae could be key to the mechanisms through which different immune responses are elicited during colonization and invasion. During an infection with C. albicans, the initial response of the innate immune system is determined by the recognition of fungal cell wall components by pattern recognition receptors (PRRs) on the surface of innate immune cells 49, 50 . Many excellent reviews have been published on this subject 10, 11, 51 , and therefore we briefly summarize only the most important aspects here (FIG. 4) . Immune responses can be stimulated not only by components from the outer layer of the cell wall but also by components from the inner layer, as these can be exposed at bud scars or by the action of antifungal drugs and host enzymes 52 . Several classes of PRR have been implicated in recognition of C. albicans PAMPs and the induction of innate host responses: the Toll-like receptors (TLRs), the C-type lectin receptors (CLRs) and the NOD-like receptors (NLRs).
Toll-like receptors.
Mammalian TLRs have an extracellular domain containing leucine-rich repeats that is responsible for the recognition of microbial structures, and a cytoplasmic Toll and interleukin-1 (IL-1) receptor (TIR) domain that is responsible for inducing intracellular responses. Shortly after the discovery of TLRs, TLR2 and TLR6 were shown to be involved in recognition of the fungal cell wall preparation zymosan 53 . Moreover, MYD88, an adaptor molecule that is shared by most TLRs, is crucial for antifungal defence in vivo 54 , strongly suggesting that TLRs have a key role in host defence against fungi. TLR2, TLR4 and TLR9 are involved in recognition of C. albicans and the induction Alternative signalling mechanisms for hypha formation yield different signalling outputs, and as a result the cell surface and immunological properties of these hyphal forms are likely to differ (denoted by different colours). a | A variety of environmental triggers modulate hypha formation through the cyclic AMP-protein kinase A complex (PKA) signalling pathway (involving the PKA regulatory subunit Bcy1 and the PKA catalytic subunits Tpk1 and Tpk2). Muramyl dipeptide (MDP) and CO 2 act directly on the adenylyl cyclase Cyr1, whereas other signals, including amino acids and glucose, act on Cyr1 indirectly. Farnesol is a quorum sensing molecule that accumulates at high C. albicans cell densities and inhibits hypha formation. Low temperatures (temp) inhibit hypha formation through the inhibitory activity of the molecular chaperone heat shock protein 90 (Hsp90) on the PKA signalling pathway, via Ras1 inhibition. Many of these signals act through the transcription factor enhanced filamentous growth 1 (Efg1) to activate the hypha-specific cyclin Hgc1. The cyclins Ccn1 (G1-S-specific cyclin) and Hgc1 form complexes with the cyclin-dependent kinase (Cdk) cell division cycle 28 (Cdc28) to promote polarized growth. b | Additional environmental factors stimulate hypha formation through alternative signalling pathways. These factors include ambient pH (through the Rim101 pathway), physical embedding of C. albicans cells within a matrix (through the transcription factor Czf1), hypoxia (which involves the transcription factors Efg1 and Efh1) and low nitrogen levels caused by starvation (which activates hyphal development through the transcription factor Candida pseudohyphal regulator 1 (Cph1)). c | In addition, hydrogen peroxide (H 2 O 2 ), ultraviolet (UV) radiation, hydroxyurea and gene deletions can lead to DNA damage or interference with cell cycle checkpoints of DNA replication, and this can also cause cell filamentation. Gpa2, guanine-nucleotide-binding (G) protein α2 subunit; Gpr1, G protein-coupled receptor 1. Nature Reviews | Microbiology 
Neutrophils
Phagocytic cells that are one of the first inflammatory cell types to migrate to the site of inflammation.
Defensins
A group of small antimicrobial peptides that have direct activity against microorganims.
of pro-inflammatory cytokine production in vitro [55] [56] [57] , and knockout mice deficient in TLR2 or TLR4 have an altered susceptibility to disseminated candidiasis 56, 58 . By contrast, TLR1 and TLR6 have redundant roles in host defence against C. albicans 59 .
C-type lectin receptors. CLRs mostly recognize polysaccharide structures of microorganisms and are probably the most important PRR family in the recognition of fungi. C. albicans is recognized by several CLRs, including dectin 1 (also known as CLEC7A), dectin 2 (also known as CLEC6A), macrophage mannose receptor 1 (MMR), dendritic cell-specific ICAM3-grabbing nonintegrin (DC-SIGN; also known as CD209), macrophage-inducible C-type lectin (MINCLE; also known as CLEC4E) and the circulating mannose-binding lectin (MBL; also known as MBPC).
Dectin 1 recognizes β-1,3-glucans in a calciumindependent manner and is involved in both ligand uptake and phagocytosis, as well as the production of pro-inflammatory cytokines 60 . Dectin 1-triggered intracellular signalling is mediated either through the adaptor molecule caspase recruitment domain-containing protein 9 (CARD9) 61 or the non-canonical nuclear factor-κB (NF-κB) pathway (through RAF1) 62 . In addition, dectin 1 cooperates with TLRs, leading to synergistic pro-inflammatory responses 63, 64 . The important role of dectin 1 and CARD9 in antifungal host defence has been confirmed by in vivo studies [65] [66] [67] , together with the discovery that host mutations in dectin 1 or CARD9 lead to primary immunodeficiencies associated with fungal infections 68, 69 . MMR is involved in recognition of C. albicans and other fungi 70 . In particular, it recognizes branched N-linked mannans from C. albicans 71 . It is unclear whether MMR has a role in phagocytosis 72 , similar to that of dectin 1, but it might mediate intracellular signals that lead to cytokine production 73, 74 . Dectin 2 is mainly present on myeloid cells and maturing inflammatory monocytes 75 . It recognizes mannoserich structures 76 and interacts with the Fcγ receptor (FcγR) to induce tumour necrosis factor (TNF) production in response to C. albicans hyphae 77 . Dectin 2 has important T helper 17 cell (T H 17 cell)-inducing activities that include the recruitment and activation of neutrophils and the induction of defensins during C. albicans infection 78 . Another CLR, DC-SIGN, is primarily expressed on mature DCs and exhibits calcium-dependent recognition of mannose-rich structures 79 . DC-SIGN mediates uptake of C. albicans yeast cells and recognizes N-linked mannans from C. albicans 80, 81 . Although DC-SIGN can induce immunosuppression by stimulating IL-10 In addition, the membrane-bound C-type lectin receptors macrophage mannose receptor 1 (MMR), dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN) and macrophage-inducible C-type lectin (MINCLE) also recognize mannose-rich structures. Dectin 1 can bind β-glucans, and dectin 2, together with the Fcγ receptor (FcγR), recognizes mannans (mannose polymers). Toll-like receptor 4 (TLR4) recognizes O-linked mannans, whereas TLR2 can recognize phospholipomannans or, together with galectin 3, recognizes β-mannosides. TLR9 is located in the cytosol and recognizes fungal DNA. Furthermore, the NOD-like receptor NLRP3 (NOD-, LRR-and pyrin domain-containing 3) forms an inflammasome complex with apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) and the enzyme caspase 1. The ligand that triggers the NLRP3 inflammasome is currently unknown. CARD9, caspase recruitment domain-containing protein 9; IFNs, interferons; IL-1β, interleukin-1β; NF-κB, nuclear factor-κB.
Inflammasome
A protein platform that triggers activation of inflammatory caspases, which process pro-interleukin-1β.
IL-1β
(Interleukin-1β). A polypeptide that is produced after infection, injury or antigenic challenge and is highly pro-inflammatory. IL-1β is primarily produced by macrophages through a pathway that is tightly regulated by the inflammasome.
T helper 1-type
(T H 1-type). A response characterized by the T H 1-type cytokine, interferon-γ.
E-cadherin
One of the cadherin proteins, which are a class of type-1 transmembrane protein that plays an important part in cell-to cell adhesion in mammalian tissues. production 82 , this effect remains to be demonstrated for fungal infections. Several other CLRs, such as MINCLE 83 and the CD36-SCARF proteins (scavenger receptor class F proteins) receptors 84 , might also contribute to the host defence against C. albicans. Galectin 3, a CLR that is mainly expressed by macrophages, is involved (in close collaboration with TLR2) in the recognition of C. albicans β-mannosides, especially at the intestinal mucosa 85, 86 . NOD-like receptors. In addition to TLRs and CLRs, which are usually associated with the cell membrane, mammals have evolved a second line of recognition receptors that are located inside the cytoplasm and can trigger an innate immune response to intracellular pathogens. Two main classes of cytoplasmic PRRs have been described to date: RIG-I-like helicases, which are mainly receptors for viruses, and NLRs. NLRs have two important functions for host defence against intracellular pathogens: recognition of bacterial peptidoglycans (by NOD1 (nucleotide-binding oligomerization domain-containing 1) and NOD2) and activation of the inflammasome. Inflammasomes are protein platforms that, on recognition of a microbial PAMP or an endogenous danger signal (for example, uric acid or ATP released from damaged epithelial cells), induce activation of caspase 1, which in turn processes pro-IL-1β and pro-IL-18 into active cytokines 87 . Although NOD1 and NOD2 are not involved in the recognition of C. albicans . Mice deficient in NLRP3 or apoptosis-associated speck-like protein containing a CARD (ASC) are more susceptible to both systemic [90] [91] [92] and mucosal 93 C. albicans infections, suggesting an important role for NLRP3-inflammasome-mediated production of IL-1 proteins during host defence against C. albicans. In addition, the inflammasome-mediated production of IL-1β and the subsequent T H 17 cell response could be a major mechanism of mucosal antifungal host defence, as detailed below.
Differential recognition of yeast and hyphae
Although much progress has been made in understanding the recognition of C. albicans PAMPs, much less is known regarding the differential recognition of the two main morphogenetic forms of this fungus: yeast and hyphae. In contrast to yeast cells, hyphae do not induce IL-12 production from DCs, but instead induce IL-4, resulting in a more anti-inflammatory immune response 94 . Hyphae also fail to induce the T H 1-type response cytokine interferon-γ (IFNγ), and this is attributed to the fact that hyphae are not recognized by TLR4 (REF. 95 ). The structure that is recognized by TLR4 on yeast cells but is absent or hidden on hyphae is unknown, but it could be a mannan structure, as TLR4 can recognize mannans 71 and mannans can induce IFNγ 74 . In addition, the differential exposure of β-glucans on the surfaces of yeast cells (exposed on the bud scars) and hyphae (no β-glucan exposure) has been proposed to account for differences in cytokine stimulation 25 . However, hyphal β-glucans can be recognized by the immune system through a process mediated by dectin 1, suggesting that β-glucan is accessible on the hyphal surface, probably because mannan fibrils are shorter and less abundant in hyphae than in yeast cells 52, 96 . In addition, differential dectin 2-mediated recognition of mannans from hyphae and yeast cells has been proposed to occur 97 , although the differences in mannan structure that are responsible for these effects are unclear 20, 98 .
Discriminating mucosal colonization and tissue invasion. The capacity to undergo a reversible yeast-hypha transformation is linked to the virulence of C. albicans 26 . When C. albicans infects humans and animals, hyphae predominate at the primary site of infiltration into epithelial cell layers and tissues, whereas yeast cells are generally found either on the epithelial cell surface or emerging from penetrating hyphae that are infiltrating tissues 99, 100 . The molecular responses of C. albicans are modulated by population density through quorum sensing, and this could modulate fungal growth in vivo 30, 101 . Nevertheless, it is thought that there is a threshold for the amount of C. albicans that is tolerated by the host. The host must keep the fungal burden below this threshold and distinguish non-pathogenic C. albicans cells from invasive and potentially life-threatening cells of the same fungus to maintain homeostasis 102 .
Sensing invasion by epithelial cells. Mucosal epithelial cells not only provide a physical barrier to pathogens but also can recognize fungi and respond by producing cytokines 103, 104 . C. albicans interacts closely with these non-phagocytic cells, both as a commensal organism (FIG. 5a) and during the active phases of invasion (FIG. 5b) . Mucosal surfaces in healthy individuals are frequently colonized with C. albicans. The small number of yeast cells present does not induce epithelial cell damage and thus does not trigger a cytokine response in epithelial cells or in mucosal macrophages. Invasive disease occurs when C. albicans crosses tissue surfaces. One mechanism by which C. albicans cells cross the epithelial surface is endocytosis, whereby the fungus is internalized by epithelial cells [105] [106] [107] . Although both yeast cells and hyphae can induce endocytosis, C. albicans hyphae are thought to be more efficient at stimulating this process. This view is supported by the observation that the efg1/efg1 mutant, which is not able to form hyphae, is much less capable of inducing endocytosis than wild-type cells 108 . Therefore, hyphae might have molecules on their cell wall that can bind to epithelial-cell receptors to induce endocytosis. One such molecule could be Als3, a hyphal CWP that binds to E-cadherin and N-cadherin and induces endocytosis 19 . C. albicans can also penetrate tissues directly, which can lead to damage of the epithelial surface. Hyphae are more potent in causing epithelial damage than yeast Nature Reviews | Microbiology 107, 109 , and the damage occurs through the production of lytic enzymes such as secreted aspartyl proteinases (SAPs) 110, 111 , although it also seems to require normal hyphal growth 109, 112 . Epithelial cells can respond to C. albicans in a twophase MAPK pathway that enables them to discriminate between the commensal yeast cells and the invasive hyphal form of the fungus 102 . In vitro and in vivo experiments indicate that the first phase of MAPK activation involves activation of the p38 MAPKs and subsequent activation of the transcription factors JUN and FOS, and that this is independent of the morphological status of C. albicans. However, a second phase involving activation of the p38 MAPKs and the extracellular signalregulated kinase (ERK) complex ERK1-ERK2 (also known as MAPK3-MAPK1) results in activation of the transcription factor MAPK phosphatase 1 (MKP1; also known as DUSP1), activation of which is necessary to induce a cytokine response by oral epithelial cells. Importantly, this second phase can be induced by C. albicans hyphae but not by the yeast form. Although it has been shown previously that, in C. albicansinfected human oral epithelium, upregulation of TLR4 expression is directly associated with protection against fungal invasion of this tissue 104 , TLR4 was not identified as an important receptor for the induction of these dual MAPK pathways. In addition, there was no evidence supporting a role for TLR2, dectin 1 or MMR. The addition of neutrophils to C. albicansinfected human oral epithelium not only strongly upregulated epithelial TLR4 expression, but also resulted in the release of LL-37, a cathelicidin-derived antimicrobial peptide that correlates with protection against infection 113 . It remains to be elucidated which PRRs mediate recognition of hyphae, allowing the epithelial cell to discriminate between colonizing and invasive C. albicans.
Mucosal antifungal immune mechanisms
In addition to epithelial cells, tissue macrophages and DCs sample the contents of the microbial flora on the mucosa. The mechanisms that allow these immune cells to discriminate between yeast cells and hyphae were unknown until recently, but the description of T H 17 cells and of the role of inflammasomes in host defence has shed new light on these processes (FIG. 5) .
CMC is a disease that is associated with defects in controlling C. albicans at the skin and mucosal surfaces. CMC can present itself as an isolated disease (autosomal-dominant CMC (AD-CMC)) or as part of a primary immunodeficiency disorder such as hyperimmunoglobulin E syndrome (HIES) or autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy (APECED). The common defect in these diseases that leads to the inability to control C. albicans at the mucosa seems to be an insufficient C. albicansinduced T H 17-type response. Patients with AD-CMC have a defect in the production of the T H 17-type cytokines IL-17A, IL-17F and IL-22 (REFS 114, 115) . Most AD-CMC patients have mutations in the coiledcoil domain of signal transducer and activator of . The switch between yeast cells and hyphae has an important role in the invasiveness of C. albicans. On the one hand, the hyphae induce cytokine production from epithelial cells by inducing not only the MAPK pathway activated by yeast cells but also a second MAPK pathway that leads to the activation of MAPK phosphatase 1 (MKP1). This triggers the production of IL-1α and IL-6. On the other hand, hyphae activate the inflammasome and induce IL-1β production in immune cells such as macrophages, which stimulates T H 17 cells to produce cytokines. T H 17 cell-produced cytokines such as IL-17 proteins activate neutrophils, whereas IL-22, another T H 17 cell-produced cytokine, induces the release of defensins from epithelial cells; both of these effects are crucial components of the mucosal antifungal defence mechanism. Modulation of tryptophan metabolism by C. albicans hyphae can down-modulate T H 17-type responses 132 . NLRP3, NOD-, LRR-and pyrin domain-containing 3; PRRs, pattern recognition receptors. transcription 1 (STAT1), which encodes one of the main adaptor molecules of the IL-23 receptor (IL-23R) and IL-12R pathways. As IL-23-mediated stimulation of IL-23R is crucial for the induction of T H 17-type responses, and the IL-12-IL-12R interaction is central for the induction of T H 1-type cytokines, defects in STAT1 result in defective T H 17-type and T H 1-type responses 116, 117 . Moreover, a recent report identified genetic defects in IL-17R and in IL-17F in some patients with CMC 118 . By contrast, patients with APECED were found to have neutralizing autoantibodies against T H 17-type cytokines 119, 120 . Furthermore, patients with HIES have a defect in STAT3, which has been shown to be crucial for the development of T H 17 cells [121] [122] [123] . These data strongly argue that the T H 17 cell subset and its cytokines, IL-17A, IL-17F and IL-22, are pivotal for maintaining the balance between colonization and mucosal disease caused by C. albicans. Indeed, it has been shown that patients with defects in the dectin 1-CARD9 pathway, which is important for an optimal C. albicansinduced T H 17-type response 68, 69 , have mucosal candidiasis. Furthermore, heterozygous carriers of an early-stop-codon mutation (Tyr238X) in the β-glucan receptor, dectin 1, leading to defective β-glucan binding, are more likely to be colonized with C. albicans when undergoing stem cell transplantation 124 . Thus, T H 17-type responses and the pathways that induce these responses play an essential part in controlling commensal C. albicans at the site of the mucosa.
Interestingly, patients with immunodeficiencies in the T H 17-type response suffer from oral and skin candidiasis, but not from vulvovaginal candidiasis (VVC). It should also be noted that two decades of research from animal models and clinical studies have revealed that adaptive immunity does not protect against VVC 125 .
A live-challenge model in humans revealed that symptomatic infection correlates with a neutrophil infiltrate in the vaginal lumen and with elevated fungal burden. Similarly, a robust vaginal polymorphonuclear neutrophil migration occurs in a subset of mice without affecting vaginal fungal burden. Furthermore, the neutrophil-chemotactic factors S100A8 and S100A9 can be produced by vaginal epithelial cells following interaction with C. albicans, demonstrating that the vaginal epithelium can contribute to a strong neutrophilic influx in VVC 126 . The pathophysiology of VVC seems to differ from that of other mucosal candidiasis disorders, and it has therefore been proposed that VVC occurs when overwhelming, rather than deficient, immune responses are present 125, 126 . The induction of the T H 17-type response requires a specific cocktail of cytokines that are produced by antigenpresenting cells: IL-23, IL-1 proteins, IL-6 and (at least in mice) transforming growth factor β1 (TGFβ1) [127] [128] [129] [130] . Whereas no differences in the induction of IL-23 and IL-6 production are found between yeast cells and hyphae, only hyphae can induce production of IL-1β by macrophages 131 . This is followed by the induction of an antifungal T H 17-type response 96 . However, the modulation of tryptophan metabolism by C. albicans hyphae can down-modulate T H 17-type responses 132 (FIG. 5) .
As mentioned above, the induction of IL-1β is mediated by the NLRP3 inflammasome. Importantly, C. albicans mutants that cannot form hyphae are unable to activate the inflammasome and therefore do not induce IL-1β secretion by macrophages 131 , suggesting that hyphae, but not yeast cells, can activate the NLRP3 inflammasome. In addition, the dectin 1 pathway is important for the production of pro-IL-1β, which can be processed into IL-1β by caspase 1 (REF. 133 ).
These observations allow us to propose a model to explain the mechanism by which tissue antigen-presenting cells discriminate between C. albicans colonization and invasion (FIG. 5) . According to this model, activation of PRRs such as dectin 1, TLR2 and MMR, through their recognition of fungal components, induces transcription of pro-IL-1β 93, 133 . Under normal circumstances of C. albicans colonization, no substantial activation of caspase 1 takes place and therefore little pro-IL-1β is processed into its active form. However, when yeast cells start to germinate into hyphae, they trigger activation of the NLRP3 inflammasome in macrophages and DCs, which leads to the activation of caspase 1 and the subsequent processing of pro-IL-1β. It should be noted that there is low-grade activation of the cellular immune response during colonization, as suggested by the presence of memory T H 17 cell responses in healthy individuals 74 . Thus, when macrophages sense the formation of C. albicans hyphae, caspase 1 is activated and active IL-1β is produced. IL-1β subsequently induces a T H 17-type response, which includes the production of IL-17 proteins and IL-22, and which is essential for the control of C. albicans at mucosal surfaces. IL-17 proteins recruit neutrophils 134 that phagocytose and kill the invading hyphae, whereas IL-22 induces epithelial cells to produce defensins 135 , which also contribute to the killing of invading C. albicans hyphae. An additional activator of the inflammasome is the ATP 136 that is released from damaged epithelial cells during mucosal invasion. Interestingly, ATP released from epithelial cells can also directly drive T H 17 cell differentiation 137 (FIG. 5b) . In conclusion, there is a two-way interaction between epithelial and immune cells during invasion: epithelial cells release cytokines and ATP to activate the inflammasome in immune cells, and IL-22 released by T H 17 cells induces defensin production from epithelial cells.
Conclusions and future perspectives
Much has recently been learned about the mechanisms through which the immune system discriminates between C. albicans colonization and invasion of the mucosa. These discoveries not only have important consequences for our understanding of the immune response to fungi, but also suggest new avenues for future research. Many details regarding the precise fungal PAMPs and the host PRRs that recognize them remain to be discovered. Moreover, several crucial questions related to mucosal antifungal immunity remain unanswered. Finally, although this Review focuses on C. albicans, it is likely that similar mechanisms contribute to the discrimination between colonization and invasion by other fungal or bacterial pathogens. The gastrointestinal tract of mammals is inhabited by hundreds of distinct species of commensal microorganisms that exist in a mutualistic relationship with the host. The commensal microbiota throughout the whole gastrointestinal tract might protect the body against invading mucosal pathogens, but when the mechanisms that control the growth of these commensals are disturbed, we might pay a high price: autoimmunity. Understanding how C. albicans influences local immune responses at mucosal surfaces may lead to the development of new and exciting ways to modulate mucosal immunity for therapeutic purposes.
